While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

Antibody drugs that target the PD-1 and VEGF pathways are in the ASCO spotlight, while doctors wrestle with how to use a new ...

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid ...

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid ...

Switching to a new drug combination — camizestrant plus a CDK4/6 inhibitor — sooner may have positive results for advanced ...

BeOne Medicines Ltd. (NASDAQ:ONC) has unveiled new data from the pivotal Phase 3 SEQUOIA trial at the 2025 ASCO Annual ...

Pack, who joined the firm’s product liability and mass torts practice as a partner, represents biotechnology and life sciences companies in complex litigation across the U.S. He joined the firm ...

IRVING, Texas and TAMPA, Fla., April 24, 2025 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced a ...

April 24, 2025 /PRNewswire/ -- Caris Life Sciences ® (Caris), a leading next ... research organizations, payers, biotech, health systems and providers to advance the quality of patient care.

Despite challenges over the past three years, life sciences employment reached a record 2.1 million in October 2024, according to the CBRE report. Between January and October biotech R&D companies ...

To the team at the North Carolina Biotechnology Center (NCBiotech), that growth is all part of the plan, with seeds planted years ago and cultivation continuing. NCBiotech drives life sciences ...

Build it, and they will come – that’s the thinking behind Inspire Bio Innovations, a new life-sciences hub in downtown Montreal that’s intended to attract biotech startups, foster research ...